Back to CVE records
Low 3.5Published Aug 17, 2026

CVE-2026-19995Webkul Bagisto RMA Message send-message cross site scripting

Updated under an hour ago ()

Does this affect you?

It affects Webkul Bagisto. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A vulnerability was determined in Webkul Bagisto up to 2.4.4. This affects an unknown part of the file /customer/account/rma/send-message of the component RMA Message Handler. This manipulation of the argument Message causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized. The vendor confirms: "The reported issues were already identified through our internal security assessment process prior to this notification and are being handled through our established internal security and development lifecycle. Some of these items have already been addressed, while the remaining items are planned for resolution in upcoming product releases."

CVSS
3.5 LOW (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:R
Weakness (CWE)
CWE-79, CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Aug 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Webkul Bagisto
webkul:bagisto
2.4.0; 2.4.1; 2.4.2; 2.4.3; 2.4.4
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • exploit

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.